Patil Rajkumar V.'s Form 4/A amendment
AmendedOKYO Pharma Ltd (OKYO) · filed Aug 7, 2026
- Accession no.
- 0001493152-26-036581
- Filed
- Aug 7, 2026, 4:15 PM ET
- Trade date
- Jul 27, 2026
- Filing delay
- 11 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Jul 29, 2026
This filing lists 1 non-derivative transaction. Open-market purchases total $5.01K. It was filed 11 days after the trade.
This amendment replaces 0001493152-26-035212 (filed Jul 29, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patil Rajkumar V.CIK 0002124067 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | COMMON STOCK | PPurchaseAcquired | +3,363 | $1.49 | +$5,010.87 | 20,030 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.